DRAGONFLY THERAPEUTICS CORPORATI has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan DRAGONFLY THERAPEUTICS 401(K) PLAN
| Measure | Date | Value |
|---|
| 2023 : DRAGONFLY THERAPEUTICS 401(K) PLAN 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $2,708,737 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $973,652 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $930,806 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $1,530,397 |
| Value of total assets at end of year | 2023-12-31 | $7,276,966 |
| Value of total assets at beginning of year | 2023-12-31 | $5,541,881 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $42,846 |
| Total interest from all sources | 2023-12-31 | $2,103 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $173,287 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $173,287 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $1,464,543 |
| Participant contributions at end of year | 2023-12-31 | $70,286 |
| Participant contributions at beginning of year | 2023-12-31 | $24,831 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $28,372 |
| Other income not declared elsewhere | 2023-12-31 | $20,897 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $1,735,085 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $7,276,966 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $5,541,881 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Investment advisory and management fees | 2023-12-31 | $41,786 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $7,206,680 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $5,517,050 |
| Interest on participant loans | 2023-12-31 | $2,103 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $982,053 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $37,482 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $930,806 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | CARON & BLETZER |
| Accountancy firm EIN | 2023-12-31 | 043499945 |
| 2022 : DRAGONFLY THERAPEUTICS 401(K) PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total transfer of assets to this plan | 2022-12-31 | $0 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $761,059 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $227,741 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $227,176 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $1,764,836 |
| Value of total assets at end of year | 2022-12-31 | $5,541,881 |
| Value of total assets at beginning of year | 2022-12-31 | $5,008,563 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $565 |
| Total interest from all sources | 2022-12-31 | $86 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $303,882 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $303,882 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $1,585,405 |
| Participant contributions at end of year | 2022-12-31 | $24,831 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $179,431 |
| Administrative expenses (other) incurred | 2022-12-31 | $565 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $533,318 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $5,541,881 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $5,008,563 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $5,517,050 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $5,008,563 |
| Interest on participant loans | 2022-12-31 | $86 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-1,307,745 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $227,176 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2022-12-31 | 043499945 |
